Culturing of cells from giant cell tumour of bone on natural and synthetic calcified substrata: the effect of leukaemia inhibitory factor and vitamin D3 on the resorbing activity of osteoclast-like cells

[1]  H. Takeuchi,et al.  In vitro bone resorption by isolated multinucleated giant cells from giant cell tumour of bone: Light and electron microscopic study , 2005, Virchows Archiv A.

[2]  G. Roodman.  Role of cytokines in the regulation of bone resorption , 2005, Calcified Tissue International.

[3]  S. J. Jones,et al.  The resorption of biological and non-biological substrates by cultured avian and mammalian osteoclasts , 2004, Anatomy and Embryology.

[4]  N. Passuti,et al.  [Filling of bone defects using biphasic macroporous calcium phosphate ceramic. Apropos of 23 cases]. , 1995, Revue de chirurgie orthopedique et reparatrice de l'appareil moteur.

[5]  T. Einhorn,et al.  Giant cell tumor of bone: A unique paradigm of stromal–hematopoietic cellular interactions , 1994, Journal of cellular biochemistry.

[6]  J. Bavaria,et al.  Pulmonary metastasis from histologically benign giant cell tumor of bone. Report of a case diagnosed by fine needle aspiration cytology. , 1994, Acta cytologica.

[7]  M. Jadoul,et al.  An ELISA for the measurement of human leukemia inhibitory factor in biological fluids and culture supernatants. , 1994, Journal of immunological methods.

[8]  C. V. van Blitterswijk,et al.  Osteoclastic resorption of calcium phosphates is potentiated in postosteogenic culture conditions. , 1994, Journal of biomedical materials research.

[9]  H. Moriya,et al.  Establishment of a cell line from a human giant cell tumor of bone. , 1993, Clinical orthopaedics and related research.

[10]  P. Schlesinger,et al.  Recent advances toward understanding osteoclast physiology. , 1993, Clinical orthopaedics and related research.

[11]  L. My,et al.  The role of recombinant human M-CSF, IL-3, GM-CSF and calcitriol in clonal development of osteoclast precursors in primate bone marrow. , 1993 .

[12]  T. Oegema,et al.  Histochemical and immunohistochemical characterization of cells constituting the giant cell tumor of bone. , 1993, Clinical orthopaedics and related research.

[13]  P. Nijweide,et al.  Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  J. Davies,et al.  The Effect of Substratum Roughness on Osteoclast-like Cells In Vitro , 1993 .

[15]  M. Lee,et al.  The role of recombinant human M-CSF, IL-3, GM-CSF and calcitriol in clonal development of osteoclast precursors in primate bone marrow. , 1993, Experimental hematology.

[16]  T. Shimoda,et al.  A flow cytometric DNA analysis of giant cell tumors of bone including two cases with malignant transformation , 1992, Cancer.

[17]  K. Lynch,et al.  Tissue response to biphasic calcium phosphate ceramic with different ratios of HA/beta TCP in periodontal osseous defects. , 1992, Journal of periodontology.

[18]  R. Baron,et al.  Identification of a functional mononuclear precursor of the osteoclast in chicken medullary bone marrow cultures , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  T. Martin,et al.  Modulation of osteoclast differentiation. , 1992, Endocrine reviews.

[20]  I. Reid,et al.  Regulation of osteoblast proliferation by leukemia inhibitory factor , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  T. Domon,et al.  Electron microscopic and histochemical studies of the mononuclear osteoclast of the mouse. , 1991, The American journal of anatomy.

[22]  G. Mundy,et al.  Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  C. Civin,et al.  Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  F. Santori,et al.  Reconstruction of Bone Defects , 1991 .

[25]  D. Tigani,et al.  Implant of Biphasic Ceramic (Tricalcium Phosphate/Hydroxyapatite) in Cystic Cavities After Bone Tumor Curettage: Preliminary Results , 1991 .

[26]  D. Metcalf.  The leukemia inhibitory factor (LIF). , 1991, International journal of cell cloning.

[27]  J. Moreau,et al.  Production of human interleukin for DA cells (HILDA)/leukemia inhibitory factor (LIF) by activated monocytes. , 1990, Cellular immunology.

[28]  D. Hilton,et al.  Leukemia inhibitory factor binds with high affinity to preosteoblastic RCT-1 cells and potentiates the retinoic acid induction of alkaline phosphatase. , 1990, Endocrinology.

[29]  T. Martin,et al.  Leukemia inhibitory factor: a novel bone-active cytokine. , 1990, Endocrinology.

[30]  Y. Sasaguri,et al.  Characterization of cells cultured from human giant-cell tumors of bone. Phenotypic relationship to the monocyte-macrophage and osteoclast. , 1990, Clinical orthopaedics and related research.

[31]  H. Yoshikawa,et al.  The use of calcium hydroxyapatite ceramic in bone tumour surgery. , 1990, The Journal of bone and joint surgery. British volume.

[32]  G. Rodan,et al.  The effect of hemopoietic growth factors on the generation of osteoclast-like cells in mouse bone marrow cultures. , 1990, Endocrinology.

[33]  G. Daculsi,et al.  Macroporous calcium phosphate ceramic for long bone surgery in humans and dogs. Clinical and histological study. , 1990, Journal of biomedical materials research.

[34]  N Passuti,et al.  Macroporous calcium phosphate ceramic performance in human spine fusion. , 1989, Clinical orthopaedics and related research.

[35]  G. Hattersley,et al.  Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures. , 1989, Endocrinology.

[36]  D. Gearing,et al.  Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Sakamoto,et al.  The effect of substrate composition and condition on resorption by isolated osteoclasts. , 1989, Bone and mineral.

[38]  J. Moreau,et al.  Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells , 1988, Nature.

[39]  P. McSheehy,et al.  1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption. , 1987, The Journal of clinical investigation.

[40]  S. Goldring,et al.  Human giant cell tumors of bone identification and characterization of cell types. , 1987, The Journal of clinical investigation.

[41]  M. Simon,et al.  Immunohistochemical study of mononuclear phagocyte antigens in giant cell tumor of bone. , 1986, The American journal of pathology.

[42]  M. Horton,et al.  Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. , 1985, Cancer research.

[43]  P. McSheehy,et al.  The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cells , 1985, The Journal of pathology.

[44]  N. Sanerkin.  Malignancy, aggressiveness, and recurrence in giant cell tumor of bone , 1980, Cancer.